TSN

Translin (TSN) is an RNA-binding protein that, together with its obligate partner TSNAX (Trax), forms the TN/TX microRNA-degrading enzyme complex with roles in germ-cell development, immune-cell metabolism, and systemic energy homeostasis. In pachytene spermatocytes, TSN localizes to nuclei and directly binds specific meiotic mRNAs and noncoding RNAs; Tsn-null males exhibit reduced sperm count and elevated meiotic apoptosis (PMID:15987823). The TN/TX complex's nuclease activity during development is required to prevent pathological adiposity and hepatic steatosis, as demonstrated by a catalytic-dead Tsnax knock-in that phenocopies Tsn deletion, while neither adipocyte/hepatocyte-specific nor adult-onset Tsn deletion recapitulates the phenotype (PMID:32408014, PMID:30647452). TSN also functions as an L-arginine-responsive transcriptional regulator that promotes T cell survival and metabolic reprogramming toward oxidative phosphorylation (PMID:27745970).

1. 2005 High

   Identifying TSN's direct RNA targets in meiotic cells established it as a nuclear RNA-binding protein essential for spermatogenesis, answering the question of whether TSN has a physiological RNA-binding role in vivo.

   Evidence UV crosslinking-immunoprecipitation, RNA gel-shift assays, and Tsn-null mouse phenotyping in pachytene spermatocytes

   PMID:15987823

   Open questions at the time

   • Functional consequence of binding each individual mRNA target is unknown
   • Whether TSN's RNA-binding in spermatocytes depends on TSNAX was not tested
   • Mechanism linking mRNA binding to meiotic apoptosis prevention is undefined
2. 2016 Medium

   Demonstrating that intracellular L-arginine alters TSN conformation and that TSN knockout impairs T cell survival revealed a non-germline, immune-metabolic function for TSN as an amino acid sensor/transcriptional regulator.

   Evidence Proteome-wide structural probing (limited proteolysis/thermal shift), mass spectrometry, CRISPR/siRNA knockout in human T cell clones

   PMID:27745970

   Open questions at the time

   • Direct transcriptional targets of TSN in T cells have not been identified
   • Whether this function requires TSNAX is unknown
   • Structural basis of L-arginine-induced conformational change is unresolved
3. 2018 Medium

   Linking TSN/TSNAX to microRNA degradation and mesenchymal cell differentiation unified the complex's nuclease function with developmental phenotypes (bone marrow failure, ectopic adipogenesis) in Tsn-null mice.

   Evidence Tsn-knockout mouse phenotyping, co-precipitation assays, integration with RISC activation studies

   PMID:29740830

   Open questions at the time

   • Specific miRNA substrates driving the mesenchymal differentiation defect were not identified
   • Findings drawn partly from review integration rather than new primary data
4. 2019 Medium

   Characterizing Tsn-null mice metabolically revealed that TSN deletion causes robust adiposity with hepatic steatosis yet preserved glucose tolerance, establishing that TSN loss creates a distinctive metabolic state distinct from simple diet-induced obesity.

   Evidence Tsn-knockout body composition, glucose/insulin tolerance tests, plasma and tissue histological/molecular analyses with adiposity-matched controls

   PMID:30647452

   Open questions at the time

   • Cell type and developmental window responsible for the phenotype were unresolved
   • Molecular mediators (miRNA targets or transcriptional programs) linking TSN loss to adiposity were not identified
5. 2020 High

   A catalytic-dead TSNAX knock-in phenocopied Tsn-null adiposity while cell-type-specific and adult-onset deletions did not, proving that the metabolic phenotype is specifically caused by loss of TN/TX microRNA-degrading enzyme activity during development rather than by protein scaffolding or adult homeostatic functions.

   Evidence Tsnax E126A knock-in, miRNA deep sequencing, conditional adipocyte/hepatocyte Cre and inducible adult Tsn deletion

   PMID:32408014

   Open questions at the time

   • The critical developmental cell type and time window remain unidentified
   • Specific miRNA substrates whose accumulation drives adiposity are not established
   • Whether TN/TX nuclease activity is also required for the meiotic or T cell phenotypes is untested
6. 2025 Medium

   Dopaminergic neuron-specific knockouts revealed asymmetric protein co-dependency — TSN deletion abolishes TSNAX expression but not vice versa — while ruling out dopaminergic TN/TX function for adiposity and psychostimulant-related behaviors.

   Evidence DAT-Cre conditional knockout of Tsn and Tsnax, immunostaining, body composition, locomotor and conditioned place preference assays

   PMID:40723911

   Open questions at the time

   • Structural basis for TSN-dependent stabilization of TSNAX is unknown
   • The critical non-dopaminergic neuronal population driving the adiposity phenotype remains unidentified
   • Whether the asymmetric co-dependency generalizes to all cell types is untested

• The developmental cell type and time window in which TN/TX nuclease activity prevents pathological adiposity remain unidentified, and the specific miRNA substrates mediating this effect are unknown.
• No cell-type-specific rescue of the metabolic phenotype has been achieved
• Comprehensive identification of in vivo TN/TX miRNA substrates across tissues is lacking
• Whether TSN's RNA-binding and transcriptional-regulator functions are mechanistically distinct from TN/TX nuclease activity is unresolved